Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics: The Market Is Overlooking Long-Term Prospects
06:22pm, Thursday, 15'th Sep 2022
Quest Diagnostics has been a pillar in my “Healthy Dividends” portfolio thanks to a safe dividend and long-term growth prospects. Quest has been a key player in the battle against COVID-19 thanks
Better Monkeypox Stock: SIGA Technologies vs. Quest Diagnostics
10:30am, Thursday, 15'th Sep 2022 The Motley Fool
One sells a treatment. The other sells a diagnostic test.
Better Monkeypox Stock: SIGA Technologies vs. Quest Diagnostics
06:30am, Thursday, 15'th Sep 2022
One sells a treatment. The other sells a diagnostic test.
Quest Diagnostics: Valuation Looks Good As Covid Testing Demand Tapers
04:31pm, Friday, 09'th Sep 2022
The Health Care sector sports relative strength during the latest market drop. Quest Diagnostics should see profits fall somewhat as Covid wanes, but there are other upside risks in this low P/E stock
Quest Diagnostics (DGX) Stock Gains on EUA for Monkeypox Test
03:40pm, Thursday, 08'th Sep 2022 Zacks Investment Research
According to Quest Diagnostics (DGX), this test can differentiate monkeypox viral DNA from other non-variola orthopoxviruses in a specimen, helping to enable a faster final diagnosis.
Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference
02:53pm, Thursday, 08'th Sep 2022
SECAUCUS, N.J. , Sept. 8, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at t
Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa
03:40pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
01:40pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
10:49am, Thursday, 01'st Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Encompass (EHC) Opens Its 4th Inpatient Rehab Unit in Illinois
05:34pm, Wednesday, 24'th Aug 2022 Zacks Investment Research
Encompass Health's (EHC) Quad Cities Rehabilitation Institute has 40 beds and serves patients who are recovering from enervating and complex illnesses and injuries.
3 Top Monkeypox Stocks to Buy Right Now
11:40am, Wednesday, 24'th Aug 2022
With the latest outbreak now reported in all 50 states per ABC News, investors may want to consider the top monkeypox stocks to buy right now. From an investment perspective, this latest health threat
Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids
12:06pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
With a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.
Quest Diagnostics' (DGX) Base Volume Revives, New Ruling Aids
09:47am, Wednesday, 17'th Aug 2022
With a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.
Illumina (ILMN) Q2 Earnings Miss Estimates, Slashes '22 View
01:34pm, Monday, 15'th Aug 2022 Zacks Investment Research
Robust sales contribution across operating segments drove Illumina's (ILMN) Q2 top line.
National Vision (EYE) Q2 Earnings Top Mark, Revenue View Cut
11:11am, Monday, 15'th Aug 2022 Zacks Investment Research
National Vision (EYE) is simultaneously facing demand headwinds across its network of stores, given the current macro environment, as well as supply challenges.
